Toxic oligomers and islet beta cell death: Guilty by association or convicted by circumstantial evidence?

Diabetologia

Volumn 53, Issue 6, 2010, Pages 1046-1056

  Zraika, S ^a   Hull, R L ^a   Verchere, C B ^b   Clark, A ^c   Potter, K J ^b   Fraser, P E ^d   Raleigh, D P ^e   Kahn, S E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c CHURCHILL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF TORONTO   (Canada)

^e STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; CELL PROTEIN; MONOMER; OLIGOMER; PANCREAS POLYPEPTIDE;

ALZHEIMER DISEASE; AMYLOIDOSIS; CELL AGGREGATION; CELL FUNCTION; CELL LOSS; CELL VOLUME; CYTOTOXICITY; DIABETOGENESIS; DISEASE COURSE; GENETIC PREDISPOSITION; HUMAN; NEUROTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OLIGOMERIZATION; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; TOXICOKINETICS;

AMYLOIDOSIS; CELL DEATH; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN-SECRETING CELLS; PANCREATIC DISEASES;

EID: 77952091224     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-1671-6     Document Type: Review

References (83)

1. SE Kahn S Zraika KM Utzschneider RL Hull 2009 The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality Diabetologia 52 1003 1012 10.1007/s00125-009-1321-z 1:CAS:528:DC%2BD1MXlt1GqtLo%3D 19326096
2. AE Butler J Janson S Bonner-Weir R Ritzel RA Rizza PC Butler 2003 Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes Diabetes 52 102 110 10.2337/diabetes.52.1.102 1:CAS:528: DC%2BD3sXisVaisA%3D%3D 12502499 (Pubitemid 36042113)
3. HL Zhao FM Lai PC Tong, et al. 2003 Prevalence and clinicopathological characteristics of islet amyloid in Chinese patients with type 2 diabetes Diabetes 52 2759 2766 10.2337/diabetes.52.11.2759 1:CAS:528:DC%2BD3sXovVagt7Y%3D 14578294 (Pubitemid 37339705)
4. A Clark CA Wells ID Buley, et al. 1988 Islet amyloid, increased A-cells, reduced B cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes Diabetes Res 9 151 159 1:STN:280:DyaL1M3ltVWlsA%3D%3D 3073901 (Pubitemid 19105415)
5. E Opie 1901 The relation of diabetes mellitus to lesions of the pancreas: hyaline degeneration of the islets of Langerhans J Exp Med 5 527 540 10.1084/jem.5.5.527 19866956
6. P Westermark 1972 Quantitative studies on amyloid in the islets of Langerhans Ups J Med Sci 77 91 94 1:STN:280:DyaE3s%2Fgtlymug%3D%3D 4116019
7. HM Schneider S Storkel W Will 1980 Amyloid of islets of Langerhans and its relation to diabetes mellitus (author's translation) Dtsch Med Wochenschr 105 1143 1147 10.1055/s-2008-1070828 1:STN:280:DyaL3M%2FovF2rtQ%3D%3D 7004825 (Pubitemid 10093057)
8. RL Hull GT Westermark P Westermark SE Kahn 2004 Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes J Clin Endocrinol Metab 89 3629 3643 10.1210/jc.2004-0405 1:CAS:528:DC%2BD2cXmslKmsb0%3D 15292279 (Pubitemid 39071447)
9. A Clark MR Nilsson 2004 Islet amyloid: a complication of islet dysfunction or an aetiological factor in type 2 diabetes? Diabetologia 47 157 169 10.1007/s00125-003-1304-4 1:CAS:528:DC%2BD2cXjtFCktLY%3D 14722650 (Pubitemid 38315352)
10. S Gebre-Medhin C Olofsson H Mulder 2000 Islet amyloid polypeptide in the islets of Langerhans: friend or foe? Diabetologia 43 687 695 10.1007/s001250051364 1:CAS:528:DC%2BD3cXjsFKisr4%3D 10907112 (Pubitemid 30409142)
11. DM Walsh DJ Selkoe 2007 A beta oligomers-a decade of discovery J Neurochem 101 1172 1184 10.1111/j.1471-4159.2006.04426.x 1:CAS:528: DC%2BD2sXmsFensrc%3D 17286590 (Pubitemid 46718812)
12. L Haataja T Gurlo CJ Huang PC Butler 2008 Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis Endocr Rev 29 303 316 10.1210/er.2007-0037 1:CAS:528:DC%2BD1cXntV2lsbo%3D 18314421 (Pubitemid 351679701)
13. A Lorenzo B Razzaboni GC Weir BA Yankner 1994 Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus Nature 368 756 760 10.1038/368756a0 1:CAS:528:DyaK2cXivFGktrk%3D 8152488 (Pubitemid 24153418)
14. DJ Selkoe 1991 The molecular pathology of Alzheimer's disease Neuron 6 487 498 10.1016/0896-6273(91)90052-2 1:CAS:528:DyaK3MXltlartrk%3D 1673054
15. MM Sousa I Cardoso R Fernandes A Guimaraes MJ Saraiva 2001 Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates Am J Pathol 159 1993 2000 1:CAS:528:DC%2BD38Xhslakuw%3D%3D 11733349 (Pubitemid 33104254)
16. MS Goldberg PT Lansbury Jr 2000 Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease? Nat Cell Biol 2 E115 E119 10.1038/35041081 1:CAS:528:DC%2BD3cXkvFCqsbw%3D 10878819
17. J Gotz LM Ittner YA Lim 2009 Common features between diabetes mellitus and Alzheimer's disease Cell Mol Life Sci 66 1321 1325 10.1007/s00018-009-9070-1 1:STN:280:DC%2BD1M3nvVOqsg%3D%3D 19266159
18. KR Bales T Verina DJ Cummins, et al. 1999 Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease Proc Natl Acad Sci USA 96 15233 15238 10.1073/pnas.96.26.15233 1:CAS:528:DC%2BD3cXhtFejug%3D%3D 10611368 (Pubitemid 30019795)
19. KR Bales T Verina RC Dodel, et al. 1997 Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition Nat Genet 17 263 264 10.1038/ng1197-263 1:CAS:528:DyaK2sXntVShsbk%3D 9354781
20. MC Irizarry BS Cheung GW Rebeck SM Paul KR Bales BT Hyman 2000 Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V717F) transgenic mice Acta Neuropathol 100 451 458 10.1007/s004010000263 1:CAS:528:DC%2BD3cXlvVKkur8%3D 11045665
21. J Vidal CB Verchere S Andrikopoulos, et al. 2003 The effect of apolipoprotein E deficiency on islet amyloid deposition in human islet amyloid polypeptide transgenic mice Diabetologia 46 71 79 1:CAS:528:DC%2BD3sXhtVKkt7g%3D 12637985 (Pubitemid 36237749)
22. YM Kuo MR Emmerling C Vigo-Pelfrey, et al. 1996 Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains J Biol Chem 271 4077 4081 10.1074/jbc.271.8.4077 1:CAS:528:DyaK28XhtlSmsL8%3D 8626743 (Pubitemid 26070502)
23. MP Lambert AK Barlow BA Chromy, et al. 1998 Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins Proc Natl Acad Sci USA 95 6448 6453 10.1073/pnas.95.11.6448 1:STN:280: DyaK1c3mtlektQ%3D%3D 9600986 (Pubitemid 28249033)
24. C Goldsbury K Goldie J Pellaud, et al. 2000 Amyloid fibril formation from full-length and fragments of amylin J Struct Biol 130 352 362 10.1006/jsbi.2000.4268 1:CAS:528:DC%2BD3cXls1anurY%3D 10940238
25. C Goldsbury J Kistler U Aebi T Arvinte GJ Cooper 1999 Watching amyloid fibrils grow by time-lapse atomic force microscopy J Mol Biol 285 33 39 10.1006/jmbi.1998.2299 1:CAS:528:DyaK1MXntFCksw%3D%3D 9878384 (Pubitemid 29034022)
26. P Westermark U Engstrom KH Johnson GT Westermark C Betsholtz 1990 Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation Proc Natl Acad Sci USA 87 5036 5040 10.1073/pnas.87.13.5036 1:CAS:528:DyaK3cXkslWnsL0%3D 2195544 (Pubitemid 20224267)
27. T Ashburn P Lansbury 1993 Interspecies sequence variations affect the kinetics and thermodynamics of amyloid formation-peptide models of pancreatic amyloid J Am Chem Soc 115 11012 11013 10.1021/ja00076a078 1:CAS:528: DyaK3sXmslWksL4%3D
28. F Ferrone 1999 Analysis of protein aggregation kinetics Methods Enzymol 309 256 274 10.1016/S0076-6879(99)09019-9 1:CAS:528:DC%2BD3cXksVKhug%3D%3D 10507029 (Pubitemid 29446454)
29. JJ Meier R Kayed CY Lin, et al. 2006 Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP Am J Physiol Endocrinol Metab 291 E1317 E1324 10.1152/ajpendo.00082.2006 1:CAS:528:DC%2BD2sXjvFWn 16849627 (Pubitemid 44904040)
30. SB Padrick AD Miranker 2002 Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis Biochemistry 41 4694 4703 10.1021/bi0160462 1:CAS:528:DC%2BD38XhslGhtrs%3D 11926832 (Pubitemid 34275671)
31. F Meng P Marek KJ Potter CB Verchere DP Raleigh 2008 Rifampicin does not prevent amyloid fibril formation by human islet amyloid polypeptide but does inhibit fibril thioflavin-T interactions: implications for mechanistic studies of beta-cell death Biochemistry 47 6016 6024 10.1021/bi702518m 1:CAS:528:DC%2BD1cXlsVKlsLs%3D 18457428 (Pubitemid 351770031)
32. T Tomiyama H Kaneko K Kataoka S Asano N Endo 1997 Rifampicin inhibits the toxicity of pre-aggregated amyloid peptides by binding to peptide fibrils and preventing amyloid-cell interaction Biochem J 322 859 865 1:CAS:528: DyaK2sXit1Ols7k%3D 9148761 (Pubitemid 27135636)
33. Abedini A, Gupta R, Marek P, et al (2010) Role of posttranslational modifications in amyloid formation. In: Ramirez-Alvarado M, Kelly JW, Dobson C (eds) Protein misfolding diseases: current and emerging principles and therapies. Wiley, Hoboken (in press)
34. AE Langkilde B Vestergaard 2009 Methods for structural characterization of prefibrillar intermediates and amyloid fibrils FEBS Lett 583 2600 2609 10.1016/j.febslet.2009.05.040 1:CAS:528:DC%2BD1MXhtVent7jL 19481541
35. R Kayed CG Glabe 2006 Conformation-dependent anti-amyloid oligomer antibodies Methods Enzymol 413 326 344 10.1016/S0076-6879(06)13017-7 1:CAS:528:DC%2BD2sXmtV2ltrc%3D 17046404 (Pubitemid 44528698)
36. R Kayed E Head JL Thompson, et al. 2003 Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 486 489 10.1126/science.1079469 1:CAS:528:DC%2BD3sXivFyms7k%3D 12702875 (Pubitemid 36444329)
37. Y Yoshiike R Minai Y Matsuo YR Chen T Kimura A Takashima 2008 Amyloid oligomer conformation in a group of natively folded proteins PLoS ONE 3 e3235 10.1371/journal.pone.0003235 18800165
38. M Masuda M Hasegawa T Nonaka, et al. 2009 Inhibition of alpha-synuclein fibril assembly by small molecules: analysis using epitope-specific antibodies FEBS Lett 583 787 791 10.1016/j.febslet.2009.01.037 1:CAS:528: DC%2BD1MXitFSls7Y%3D 19183551
39. CY Lin T Gurlo R Kayed, et al. 2007 Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced beta-cell apoptosis in h-IAPP transgenic mice Diabetes 56 1324 1332 10.2337/db06-1579 1:CAS:528:DC%2BD2sXltlanurw%3D 17353506 (Pubitemid 46715613)
40. HL Zhao Y Sui J Guan, et al. 2009 Amyloid oligomers in diabetic and nondiabetic human pancreas Transl Res 153 24 32 10.1016/j.trsl.2008.10.009 1:CAS:528:DC%2BD1cXhsFagsLjM 19100955
41. J Miklossy H Qing A Radenovic, et al. 2008 Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes Neurobiol Aging 10.1016/j.neurobiolaging.2008.08.019 18950899
42. DJ Figueroa XP Shi SJ Gardell CP Austin 2001 Abetapp secretases are co-expressed with Abetapp in the pancreatic islets J Alzheimer's Dis 3 393 396 1:CAS:528:DC%2BD3MXnvF2lsbw%3D
43. JD Green C Goldsbury J Kistler GJ Cooper U Aebi 2004 Human amylin oligomer growth and fibril elongation define two distinct phases in amyloid formation J Biol Chem 279 12206 12212 10.1074/jbc.M312452200 1:CAS:528:DC%2BD2cXitl2hu7s%3D 14704152 (Pubitemid 38445785)
44. RA Ritzel JJ Meier CY Lin JD Veldhuis PC Butler 2007 Human islet amyloid polypeptide oligomers disrupt cell coupling, induce apoptosis, and impair insulin secretion in isolated human islets Diabetes 56 65 71 10.2337/db06-0734 1:CAS:528:DC%2BD2sXhtVWltrw%3D 17192466 (Pubitemid 46263112)
45. J Janson WC Soeller PC Roche, et al. 1996 Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide Proc Natl Acad Sci USA 93 7283 7288 10.1073/pnas.93.14.7283 1:CAS:528:DyaK28Xkt1Wgtrk%3D 8692984 (Pubitemid 26243541)
46. WP Wong DW Scott CL Chuang, et al. 2008 Spontaneous diabetes in hemizygous human amylin transgenic mice that developed neither islet amyloid nor peripheral insulin resistance Diabetes 57 2737 2744 10.2337/db06-1755 1:CAS:528:DC%2BD1MXhs1Kntrk%3D 18633116
47. AE Butler J Janson WC Soeller PC Butler 2003 Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid Diabetes 52 2304 2314 10.2337/diabetes.52.9.2304 1:CAS:528:DC%2BD3sXntFeqtbY%3D 12941770 (Pubitemid 37059501)
48. A Shameli J Yamanouchi S Thiessen P Santamaria 2007 Endoplasmic reticulum stress caused by overexpression of islet-specific glucose-6-phosphatase catalytic subunit-related protein in pancreatic beta-cells Rev Diabet Stud 4 25 32 10.1900/RDS.2007.4.25 17565413 (Pubitemid 47450222)
49. L Socha D Silva S Lesage C Goodnow N Petrovsky 2003 The role of endoplasmic reticulum stress in nonimmune diabetes: NOD.k iHEL, a novel model of beta cell death Ann N Y Acad Sci 1005 178 183 10.1196/annals.1288.022 1:STN:280:DC%2BD3srps1Kgsw%3D%3D 14679055 (Pubitemid 38507749)
50. B Konarkowska JF Aitken J Kistler S Zhang GJ Cooper 2006 The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells FEBS J 273 3614 3624 10.1111/j.1742-4658.2006.05367.x 1:CAS:528: DC%2BD28XovFGltro%3D 16884500 (Pubitemid 44086959)
51. J Janson RH Ashley D Harrison S McIntyre PC Butler 1999 The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles Diabetes 48 491 498 10.2337/diabetes.48.3.491 1:CAS:528:DyaK1MXhsFymsbk%3D 10078548 (Pubitemid 29106861)
52. ET Bell 1959 Hyalinization of the islets of Langerhans in nondiabetic individuals Am J Pathol 35 801 805 1:STN:280:DyaG1M7gtVSnsA%3D%3D 13670312
53. S Deng M Vatamaniuk X Huang, et al. 2004 Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects Diabetes 53 624 632 10.2337/diabetes.53.3.624 1:CAS:528:DC%2BD2cXhvFelu78%3D 14988246 (Pubitemid 38270631)
54. S Zraika RL Hull J Udayasankar, et al. 2009 Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis Diabetologia 52 626 635 10.1007/s00125-008-1255-x 1:CAS:528:DC%2BD1MXisFSisrs%3D 19148619
55. L Marzban A Tomas TC Becker, et al. 2008 Small interfering RNA-mediated suppression of proislet amyloid polypeptide expression inhibits islet amyloid formation and enhances survival of human islets in culture Diabetes 57 3045 3055 10.2337/db08-0485 1:CAS:528:DC%2BD1MXhsleis74%3D 18694973
56. KJ Potter LA Scrocchi GL Warnock, et al. 2009 Amyloid inhibitors enhance survival of cultured human islets Biochim Biophys Acta 1790 566 574 1:CAS:528:DC%2BD1MXmvFGht7k%3D 19264107
57. S Bhattacharya JN Latha R Kumresan S Singh 2007 Cloning and expression of human islet amyloid polypeptide in cultured cells Biochem Biophys Res Commun 356 622 628 10.1016/j.bbrc.2007.03.016 1:CAS:528:DC%2BD2sXjvFOnurc%3D 17374526 (Pubitemid 46499010)
58. SM Vaiana R Ghirlando WM Yau WA Eaton J Hofrichter 2008 Sedimentation studies on human amylin fail to detect low-molecular-weight oligomers Biophys J 94 L45 L47 10.1529/biophysj.107.125146 1:CAS:528:DC%2BD1cXjsleqtbo%3D 18223003
59. R Soong JR Brender PM Macdonald A Ramamoorthy 2009 Association of highly compact type II diabetes related islet amyloid polypeptide intermediate species at physiological temperature revealed by diffusion NMR spectroscopy J Am Chem Soc 131 7079 7085 10.1021/ja900285z 1:CAS:528:DC%2BD1MXlt1Cltrg%3D 19405534
60. M Anguiano RJ Nowak PT Lansbury Jr 2002 Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes Biochemistry 41 11338 11343 10.1021/bi020314u 1:CAS:528:DC%2BD38XmtlynsL4%3D 12234175
61. T Tomiyama S Asano Y Suwa, et al. 1994 Rifampicin prevents the aggregation and neurotoxicity of amyloid beta protein in vitro Biochem Biophys Res Commun 204 76 83 10.1006/bbrc.1994.2428 1:CAS:528:DyaK2cXmsVKit78%3D 7945395 (Pubitemid 24335264)
62. T Tomiyama A Shoji K Kataoka, et al. 1996 Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger J Biol Chem 271 6839 6844 10.1074/jbc.271.12.6839 1:CAS:528:DyaK28XhvVyisb0%3D 8636108 (Pubitemid 26104118)
63. L Khemtemourian JA Killian JW Hoppener MF Engel 2008 Recent insights in islet amyloid polypeptide-induced membrane disruption and its role in beta-cell death in type 2 diabetes mellitus Exp Diabetes Res 2008 421287 18483616
64. S Casas A Novials F Reimann R Gomis FM Gribble 2008 Calcium elevation in mouse pancreatic beta cells evoked by extracellular human islet amyloid polypeptide involves activation of the mechanosensitive ion channel TRPV4 Diabetologia 51 2252 2262 10.1007/s00125-008-1111-z 1:CAS:528: DC%2BD1cXhtlCjs7%2FL 18751967
65. MF Engel L Khemtemourian CC Kleijer, et al. 2008 Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane Proc Natl Acad Sci USA 105 6033 6038 10.1073/pnas.0708354105 1:CAS:528:DC%2BD1cXltlGitLo%3D 18408164 (Pubitemid 351758394)
66. JW Kelly 2000 Mechanisms of amyloidogenesis Nat Struct Biol 7 824 826 10.1038/82815 1:STN:280:DC%2BD3M%2FhvFyltQ%3D%3D 11017183
67. S Zhang H Liu J Liu CA Tse M Dragunow GJ Cooper 2006 Activation of activating transcription factor 2 by p38 MAP kinase during apoptosis induced by human amylin in cultured pancreatic beta-cells FEBS J 273 3779 3791 10.1111/j.1742-4658.2006.05386.x 1:CAS:528:DC%2BD28XovFynsbc%3D 16869889 (Pubitemid 44172615)
68. S Zhang H Liu H Yu GJ Cooper 2008 Fas-associated death receptor signaling evoked by human amylin in islet beta-cells Diabetes 57 348 356 10.2337/db07-0849 1:CAS:528:DC%2BD1cXhvVOktrk%3D 17977957
69. S Zhang J Liu M Dragunow GJ Cooper 2003 Fibrillogenic amylin evokes islet beta-cell apoptosis through linked activation of a caspase cascade and JNK1 J Biol Chem 278 52810 52819 10.1074/jbc.M308244200 1:CAS:528:DC%2BD3sXpvFGjtrc%3D 14532296 (Pubitemid 38035879)
70. S Zhang J Liu G MacGibbon M Dragunow GJ Cooper 2002 Increased expression and activation of c-Jun contributes to human amylin-induced apoptosis in pancreatic islet beta-cells J Mol Biol 324 271 285 10.1016/S0022-2836(02)01044-6 1:CAS:528:DC%2BD38Xos1Gntrg%3D 12441106 (Pubitemid 35379027)
71. JS Pedersen DE Otzen 2008 Amyloid-a state in many guises: survival of the fittest fibril fold Protein Sci 17 2 10 10.1110/ps.073127808 1:CAS:528:DC%2BD1cXmt1Crtg%3D%3D 18042680
72. JC Ehrlich IM Ratner 1961 Amyloidosis of the islets of Langerhans. A restudy of islet hyalin in diabetic and non-diabetic individuals Am J Pathol 38 49 59 1:STN:280:DyaF3c%2FksFKguw%3D%3D 13726023
73. T An GI Kaye 1978 Amyloid formation in insulinoma Arch Pathol Lab Med 102 227 232 1:STN:280:DyaE1c7msFWhug%3D%3D 206226 (Pubitemid 8349408)
74. M Couce LA Kane TD O'Brien, et al. 1996 Treatment with growth hormone and dexamethasone in mice transgenic for human islet amyloid polypeptide causes islet amyloidosis and beta-cell dysfunction Diabetes 45 1094 1101 10.2337/diabetes.45.8.1094 1:CAS:528:DyaK28XkslSktLY%3D 8690157 (Pubitemid 26260163)
75. DM Walsh BP Tseng RE Rydel MB Podlisny DJ Selkoe 2000 The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain Biochemistry 39 10831 10839 10.1021/bi001048s 1:CAS:528: DC%2BD3cXlsV2itL4%3D 10978169
76. H Kokubo R Kayed CG Glabe H Yamaguchi 2005 Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain Brain Res 1031 222 228 10.1016/j.brainres.2004.10.041 1:CAS:528:DC%2BD2MXkvFaqsA%3D%3D 15649447 (Pubitemid 40093074)
77. JL Tomic A Pensalfini E Head CG Glabe 2009 Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction Neurobiol Dis 35 352 358 10.1016/j.nbd.2009.05.024 1:CAS:528:DC%2BD1MXpsFylsrk%3D 19523517
78. AE Roher MO Chaney YM Kuo, et al. 1996 Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease J Biol Chem 271 20631 20635 10.1074/jbc.271.34.20631 1:CAS:528:DyaK28Xlt1yns70%3D 8702810 (Pubitemid 26281842)
79. DJ Selkoe 2008 Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior Behav Brain Res 192 106 113 10.1016/j.bbr.2008.02.016 1:CAS:528:DC%2BD1cXmvV2itr8%3D 18359102
80. DM Walsh I Klyubin JV Fadeeva, et al. 2002 Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 535 539 10.1038/416535a 1:CAS:528:DC%2BD38XivVOntL8%3D 11932745 (Pubitemid 34288854)
81. MP Lambert KL Viola BA Chromy, et al. 2001 Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies J Neurochem 79 595 605 10.1046/j.1471-4159.2001.00592.x 1:CAS:528:DC%2BD3MXotlShtb8%3D 11701763 (Pubitemid 33029933)
82. BM Austen KE Paleologou SA Ali MM Qureshi D Allsop OM El-Agnaf 2008 Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's beta-amyloid peptide Biochemistry 47 1984 1992 10.1021/bi701415b 1:CAS:528:DC%2BD1cXltFWntA%3D%3D 18189413 (Pubitemid 351287124)
83. F Yang GP Lim AN Begum, et al. 2005 Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo J Biol Chem 280 5892 5901 10.1074/jbc.M404751200 1:CAS:528:DC%2BD2MXhtlClt7w%3D 15590663 (Pubitemid 40280072)